Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: A prospective multicenter study

Endoscopy

Volumn 45, Issue 7, 2013, Pages 516-525

  Van Vilsteren, F G I ^a   Alvarez Herrero, L ^a,b   Pouw, R E ^a   Schrijnders, D ^a   Sondermeijer, C M T ^a   Bisschops, R ^c   Esteban, J M ^d   Meining, A ^e   Neuhaus, H ^f,g   Parra Blanco, A ^a,m,n   Pech, O ^h   Ragunath, K ⁱ   Rembacken, B ^j   Schenk, B E ^k   Visser, M ^a   Kate, F J W Ten ^a   Meijer, S L ^a   Reitsma, J B ^k,l   Weusten, B L A M ^a,b   Schoon, E J ^m   Bergman, J J G H M ^a   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f Children s Hospital   (Germany)

^g HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^h DR HORST SCHMIDT KLINIKEN   (Germany)

ⁱ QUEEN S MEDICAL CENTRE   (United Kingdom)

^j ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^k Isala Klinieken ^*  (Chile)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m CATHARINA HOSPITAL   (Netherlands)

ⁿ PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RANITIDINE; SUCRALFATE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER PATIENT; CIRCUMFERENTIAL RADIOFREQUENCY ABLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ENDOSCOPIC SURGERY; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; REFLUX ESOPHAGITIS; RISK FACTOR; SCAR; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; CATHETER ABLATION; DECISION SUPPORT TECHNIQUES; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84879497907     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0032-1326423     Document Type: Article

References (25)

1. Fleischer D. E., Overholt B. F., Sharma V. K. et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc: 2008; 68 867 876
2. Gondrie J. J., Pouw R. E., Sondermeijer C. M. et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy: 2008; 40 359 369 (Pubitemid 351696372)
3. Gondrie J. J., Pouw R. E., Sondermeijer C. M. et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy: 2008; 40 370 379 (Pubitemid 351696373)
4. Pouw R. E., Wirths K., Eisendrath P. et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol: 2010; 8 23 29
5. Shaheen N. J., Sharma P., Overholt B. F. et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med: 2009; 360 2277 2288
6. Van Vilsteren F. G., Pouw R. E., Seewald S. et al. Stepwise radical endoscopic resection vs. radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut: 2011; 60 765 773
7. Pouw R. E., Bisschops R., Pech O. et al. Safety outcomes of balloon-based circumferential radiofrequency ablation after focal endoscopic resection of early Barrett's neoplasia in 118 patients: results of an ongoing European multicenter study. Gastrointest Endosc: 2010; 71 AB126
8. Van Vilsteren F. G., Bergman J. J. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus. Gastrointest Endosc Clin N Am: 2010; 20 55 74, vi
9. Sharma P., Dent J., Armstrong D. et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology: 2006; 131 1392 1399 (Pubitemid 44708937)
10. Akiyama T., Inamori M., Iida H. et al. Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis. World J Gastroenterol: 2010; 16 484 489
11. Badreddine R. J., Prasad G. A., Wang K. K. et al. Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus. Gastrointest Endosc: 2010; 71 697 703
12. Chak A., Falk G., Grady W. M. et al. Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol: 2009; 104 1913 1921
13. Herrero L. A., Van Vilsteren F. G., Pouw R. E. et al. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm. Gastrointest Endosc: 2011; 73 682 690
14. Korst R. J., Santana-Joseph S., Rutledge J. R. et al. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: a single-center, phase II clinical trial. J Thorac Cardiovasc Surg: 2011; 142 1168 1173
15. Krishnan K., Pandolfino J. E., Kahrilas P. J. et al. Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology: 2012; 143 576 581
16. Lyday W. D., Corbett F. S., Kuperman D. A. et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy: 2010; 42 272 278
17. Pech O., Behrens A., May A. et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut: 2008; 57 1200 1206
18. Steevens J., Schouten L. J., Driessen A. L. et al. A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett's esophagus. Cancer Epidemiol Biomarkers Prev: 2011; 20 345 358
19. Weston A. P., Sharma P., Mathur S. et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol: 2004; 99 1657 1666 (Pubitemid 39237488)
20. Yachimski P., Puricelli W. P., Nishioka N. S. Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol: 2008; 6 302 308
21. Akiyama J., Marcus S. N., Triadafilopoulos G. Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett's esophagus. Dig Dis Sci: 2012; 57 2625 2632
22. Bremner C. G., Lynch V. P., Ellis F. H. et al. Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery: 1970; 68 209 216
23. Dvorak K., Payne C. M., Chavarria M. et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut: 2007; 56 763 771 (Pubitemid 46854189)
24. Iascone C., DeMeester T. R., Little A. G. et al. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg: 1983; 118 543 549 (Pubitemid 13079292)
25. Wakelin D. E., Al-Mutawa T., Wendel C. et al. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc: 2003; 58 350 355 (Pubitemid 38259820)